Company
Carmell
- Business model
- B2B
Record updated 28 September 2026
About
Carmell has created a unique and highly innovative patented technology based on biologically-active materials manufactured from human blood plasma. Their proprietary process binds and cross-links lyophilized plasma into solid and semi-solid plasma-based materials. These Plasma-based Bioactive Materials (PBMs) contain highly concentrated natural regenerative factors that promote healing in various clinical settings, reduce infections, and, as a result, lower healthcare costs.